id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-1997-N-0041-0022,FDA,FDA-1997-N-0041,Acknowledgement Letter to Jerome Stevens Pharamceuticals,Other,ACK-Acknowledgement Letter,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2009-01-25T01:36:45Z,,0,0,09000064805cfc2c
FDA-1997-N-0041-0016,FDA,FDA-1997-N-0041,Knoll Pharmaceutical Company - Supplement (SUP3),Other,SUP-Supplement,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2013-07-28T01:52:42Z,,0,0,09000064805cfc25
FDA-1997-N-0041-0017,FDA,FDA-1997-N-0041,Knoll Pharmaceutical Company - Supplement (SUP4),Other,SUP-Supplement,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2009-01-25T01:36:38Z,,0,0,09000064805cfc26
FDA-1997-N-0041-0014,FDA,FDA-1997-N-0041,Knoll Pharmaceutical Company to FDA - Letter,Other,LET-Letter,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2013-07-27T22:09:10Z,,0,0,09000064805cfc1e
FDA-1997-N-0041-0010,FDA,FDA-1997-N-0041,Knoll Pharmaceutical Company - Supplement (SUP1),Other,SUP-Supplement,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2013-07-27T22:09:10Z,,0,0,09000064805cfc19
FDA-1997-N-0041-0009,FDA,FDA-1997-N-0041,"FDA Interim Response to Mason, Taylor & Colicchio - Letter",Other,LET-Letter,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2009-01-25T01:36:27Z,,0,0,09000064805cfc11
FDA-1997-N-0041-0031,FDA,FDA-1997-N-0041,"FDA Response to Knoll Pharmaceutical, Inc.  - Answer",Other,ANS-Answer,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2013-07-27T22:09:09Z,,0,0,09000064805cfc06
FDA-1997-N-0041-0019,FDA,FDA-1997-N-0041,Knoll Pharmaceutical Company to FDA - Letter,Other,LET-Letter,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2013-07-27T22:09:10Z,,0,0,09000064805cfc29
FDA-1997-N-0041-0015,FDA,FDA-1997-N-0041,Knoll Pharmaceutical Company - Supplement (SUP2),Other,SUP-Supplement,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2013-08-11T02:52:27Z,,0,0,09000064805cfc22
FDA-1997-N-0041-0005,FDA,FDA-1997-N-0041,"Knoll Pharmaceutical Company [Buc & Beardsley] to FDA/CDER  September 24, 1997 - Letter",Other,LET-Letter,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2013-07-27T22:09:09Z,,0,0,09000064805cfc04
FDA-1997-N-0041-0026,FDA,FDA-1997-N-0041,"FDA Response to Mason, Taylor & Colicchio - Petition Denial (PDN3)",Other,PDN-Petition Denial,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2013-07-27T22:09:10Z,,0,0,09000064805cfc3a
FDA-1997-N-0041-0025,FDA,FDA-1997-N-0041,FDA Response to Knoll Pharmaceutical Company - Petition Denial (PDN2),Other,PDN-Petition Denial,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2009-01-25T01:36:49Z,,0,0,09000064805cfc39
FDA-1997-N-0041-0023,FDA,FDA-1997-N-0041,Knoll Pharmaceutical Company - Supplement (SUP5),Other,SUP-Supplement,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2013-08-11T02:52:27Z,,0,0,09000064805cfc32
FDA-1997-N-0041-0024,FDA,FDA-1997-N-0041,FDA Response to Jerome Stevens Pharmaceutical - Petition Denial (PDN1),Other,PDN-Petition Denial,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2009-01-25T01:36:48Z,,0,0,09000064805cfc38
FDA-1997-N-0041-0012,FDA,FDA-1997-N-0041,Knoll Pharmaceutical Company - Citizen Petition (CP3),Other,CP-Citizen Petition,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2009-01-25T01:36:31Z,,0,0,09000064805cfc1c
FDA-1997-N-0041-0011,FDA,FDA-1997-N-0041,"Jones Medical Industries (King & Spading) to FDA/CDER, June 12, 1998 - Letter",Other,LET-Letter,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2013-08-11T04:24:36Z,,0,0,09000064805cfc1b
FDA-1997-N-0041-0008,FDA,FDA-1997-N-0041,Acknowledgement Letter to Knoll Pharmaceutical Company,Other,ACK-Acknowledgement Letter,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2009-01-25T01:36:26Z,,0,0,09000064805cfc09
FDA-1997-N-0041-0020,FDA,FDA-1997-N-0041,Knoll Pharmaceutical Company to FDA - Letter,Other,LET-Letter,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2013-07-27T22:09:10Z,,0,0,09000064805cfc2a
FDA-1997-N-0041-0018,FDA,FDA-1997-N-0041,FDA Response to Knoll Pharmaceutical Company - Petition Approval,Other,PAV-Petition Approval,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2013-07-27T22:09:10Z,,0,0,09000064805cfc28
FDA-1997-N-0041-0021,FDA,FDA-1997-N-0041,"Jerome Stevens Pharmaceuticals Inc., (Reed Smith LLP) - Citzen Petition (CP4)",Other,CP-Citizen Petition,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2009-01-25T01:36:44Z,,0,0,09000064805cfc2b
FDA-1997-N-0041-0013,FDA,FDA-1997-N-0041,Acknowledgement Letter to Knoll Pharmaceutical Company,Other,ACK-Acknowledgement Letter,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2009-01-25T01:36:33Z,,0,0,09000064805cfc1d
FDA-1997-N-0041-0007,FDA,FDA-1997-N-0041,Knoll Pharmaceutical Company - Citizen Petition (CP2),Other,CP-Citizen Petition,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2009-01-25T01:36:24Z,,0,0,09000064805cfc08
FDA-1997-N-0041-0032,FDA,FDA-1997-N-0041,FDA/CDER Response to Nancy L Buc [Buc & Beardsley] - Answer,Other,ANS-Answer,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2013-07-27T22:09:10Z,,0,0,09000064805cfc20
FDA-1997-N-0041-0027,FDA,FDA-1997-N-0041,"Guidance for Industry on Levothyroxine Sodium Products-Enforcement of August 14, 2001, Compliance Date and Submission of New Applications; Guidance Document",Other,GDL-Guidance (Supporting and Related Materials),2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2013-07-28T01:52:42Z,,0,0,09000064805cfc47
FDA-1997-N-0041-0033,FDA,FDA-1997-N-0041,FDA/CDER Response  to Patton Boggs - Answer,Other,ANS-Answer,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2013-07-27T22:09:10Z,,0,0,09000064805cfc40
FDA-1997-N-0041-0006,FDA,FDA-1997-N-0041,"Mason, Taylor & Colicchio - Citizen Petition (CP1)",Other,CP-Citizen Petition,2009-01-24T05:00:00Z,2009,1,2009-01-24T05:00:00Z,,2009-01-25T01:36:23Z,,0,0,09000064805cfc05
FDA-1997-N-0041-0004,FDA,FDA-1997-N-0041,"Guidance for Industry on Levothyroxine Sodium Products-Enforcement of August 14, 2001, Compliance Date and Submission of New Applications; Availability",Notice,NAD-Notice of Availability of Data,2001-07-18T04:00:00Z,2001,7,,,2009-01-24T19:59:15Z,,0,0,09000064805cfc48
FDA-1997-N-0041-0003,FDA,FDA-1997-N-0041,Prescription Drug Products; Levothyroxine Sodium; Extension of Compliance Date,Notice,N-Notice,2000-04-26T04:00:00Z,2000,4,,,2009-01-24T19:56:57Z,,0,0,09000064805cfc27
FDA-1997-N-0041-0001,FDA,FDA-1997-N-0041,Prescription Drug Products; Levothyroxine Sodium,Notice,N-Notice,1997-08-20T04:00:00Z,1997,8,1997-08-20T04:00:00Z,1997-10-15T03:59:59Z,2009-01-24T19:53:02Z,,0,0,09000064805cfc01
FDA-1997-N-0041-0002,FDA,FDA-1997-N-0041,Prescription Drug Products; Levothyroxine Sodium [re FDA-1997-N-0041-0001,Notice,N-Notice,1997-08-20T04:00:00Z,1997,8,1997-08-20T04:00:00Z,1997-10-15T03:59:59Z,2009-01-24T19:55:06Z,,0,0,09000064805cfc03